Pura Vida Investments, LLC Acer Therapeutics Inc. Transaction History

Pura Vida Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$17.71 - $21.6 $740,189 - $902,772	-41,795 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$14.81 - $20.22 $723,690 - $988,050	-48,865 Reduced 53.9%	41,795 $0
Q4 2017 Feb 14, 2018	BUY	$11.81 - $19.35 $1.07 Million - $1.75 Million	90,660	90,660 $0

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.